CVS Health Corporation · NYSE:CVS
CVS Health — Caremark RX — Merger or Acquisition (January 2007)
20 slides from CVS Health's merger presentation, Jan 18, 2007
Slide 1: CVS/Caremark Merger Overview
CVS/Caremark Merger Overview Name: Symbol: Management Team: Board Composition: Headquarters: Expected Closing: CVS/Caremark Corporation To be listed on NYSE under "CVS" o Mac Crawford - Chairman o Tom Ryan - President and CEO o Dave Rickard - CFO o Howard McLure - President Caremark Pharmacy Service
Slide 2: CVS/Caremark Merger Capitalizes on Evolving Industry Trends
CVS/Caremark Merger Capitalizes on Evolving Industry Trends Market Trends Cost Containment Growing Consumerism Cost Shift to Consumer Focus on Wellness Medicare Part D Robust Generic Pipeline Specialty Products CVS/Caremark Merger Benefit Purchasing advantage, operating efficiencies and improved acc
Slide 3: CVS/Caremark Merger is in Best Interest of Shareholders, Customers and Consumers
CVS/Caremark Merger is in Best Interest of Shareholders, Customers and Consumers o Significant strategic benefits o Financial benefits are substantial and concrete o Anti-trust clearance; February 2007 close o Realize benefits in 2007 selling season o Strong investment grade credit; 150M share repur
Slide 4: Enhances Shareholder Value: Compelling Strategic Benefits
CVS/Caremark Merger Enhances Shareholder Value Compelling Strategic Benefits o Uniquely positioned to capitalize on evolving trends o Superior upside in creation of new services and products o Better control over costs for payors o Improves choice and accessibility, and promotes better health outcom
Slide 5: Enhances Shareholder Value: Substantial Financial Benefits
CVS/Caremark Merger Enhances Shareholder Value Compelling Strategic Benefits o Uniquely positioned to capitalize on evolving trends o Superior upside in creation of new services and products o Better control over costs for payors o Improves choice and accessibility, and promotes better health outcom
Slide 6: Enhances Shareholder Value: Clear Path to Close
CVS/Caremark Merger Enhances Shareholder Value Compelling Strategic Benefits o Uniquely positioned to capitalize on evolving trends o Superior upside in creation of new services and products o Better control over costs for payors o Improves choice and accessibility, and promotes better health outcom
Slide 7: Enhances Shareholder Value: Enhanced Business Opportunity
CVS/Caremark Merger Enhances Shareholder Value Compelling Strategic Benefits Substantial Financial Benefits Clear Path to Close Enhanced Business Opportunity o Uniquely positioned to capitalize on evolving trends o Superior upside in creation of new services and products o Better control over costs
Slide 8: Enhances Shareholder Value
CVS/Caremark Merger Enhances Shareholder Value Compelling Strategic Benefits "Uniquely positioned to capitalize on evolving trends "Superior upside in creation of new services and products "Better control over costs for payors "Improves choice and accessibility, and promotes better health outcomes f
Slide 9: Enhances Shareholder Value
CVS/Caremark Merger Enhances Shareholder Value Compelling Strategic Benefits "Uniquely positioned to capitalize on evolving trends "Superior upside in creation of new services and products "Better control over costs for payors "Improves choice and accessibility, and promotes better health outcomes f
Slide 10: Near-Term Sources of Revenue That Only a CVS/Caremark Combination Can Derive
Near-Term Sources of Revenue That Only a CVS/Caremark Combination Can Derive Incremental revenue opportunities from $800M to $1B in 2008; significant growth thereafter Examples include: In-store pickup for mail customers and targeted retail-to-mail conversion Front-store offers for PBM members in-st
Slide 11: Superior Financial Profile
Superior Financial Profile Strong investment grade credit rating Pro forma LTM Revenue $ 72,896 EBITDA $ 4,306 % Margin 5.9% Net Income $ 2,420 Debt / EBITDA 1.5x Free Cash Flow $ 1,899 Note -- Based on the simple addition of reported results for the last twelve months ended September 30, 2006 with
Slide 12: A Clearly Superior Offer
A Clearly Superior Offer Significant strategic benefits Substantial financial benefits Clients supportive February 2007 close Strong management team Successful large-scale integrations Highly conditional offer No strategic advantage Financial benefits suspect Client attrition Uncertain timing, IF EV
Slide 13: Dispelling the Myths
Dispelling the Myths MYTH REALITY Incentive Alignment " We "make money when patients " Well understood that retail and PBM incentives are and clients spend money" aligned with patients and payors " Integrated offering delivers more value to clients Financial Flexibility " ESRX would have "significan
Slide 14: CVS/CMX Provides Immediate, Superior Value Offer
CVS/CMX Provides Immediate, Superior Value Offer Pro Forma CMX Ownership Targeted Annual Cost Synergies Incremental Revenue Opportunities Anticipated 2008 Accretion Expected Closing Selling Season Conditions to Close o 1.67 shares of CVS for each CMX of CMX o $2.00 per share in special cash dividend
Slide 15: CVS/CMX Merger with Certainty to Close vs. ESRX's Highly Conditional Offer
with Certainty to Close vs. ESRX's Highly Conditional Offer Timing Regulatory Due Diligence CMX Board of Director Approval Financing Termination of Existing CVS/CMX Merger-of-Equal Agreement Shareholder Approval CVS/CMX Merger o February 2007 o Approval received without second request o Not a condit
Slide 16: The Right Combination
CVS/Caremark: The Right Combination o Significant strategic benefits o Financial benefits are substantial and concrete o Anti-trust clearance; February 2007 close o Realize benefits in 2007 selling season o Strong investment grade credit; 150M share repurchase (~10%) o Proven management teams 17
Slide 17: Cautionary Statement Regarding Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements This document contains certain forward-looking statements about CVS and Caremark. When used in this document, the words "anticipates", "may", "can", "believes", "expects", "projects", "intends", "likely", "will", "to be" and any similar expre
Slide 18: Important Information
Important Information CVS and Caremark have filed a preliminary joint proxy statement/prospectus with the SEC in connection with the proposed merger. CVS and Caremark urge investors and stockholders to read the joint proxy statement/prospectus when it becomes available and any other relevant documen
Slide 19: Creating the Premier Pharmacy Services Provider
Creating the Premier Pharmacy Services Provider January 2007 20
Slide 20: CVS/Caremark: Creating the Premier Pharmacy Services Provider
CVS/CAREMABK Creating the Premier Pharmacy Services Provider 20